Document is current
Any future updates will be listed below
-
Authors
Wei, Chunyao
Kesner, Barry
Weissbein, Uri
Wasserzug-Pash, Peera
Das, Priyojit https://orcid.org/0000-0002-6774-6718
Lee, Jeannie T. https://orcid.org/0000-0001-7786-8850
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01-GM58839)
- License Information
-
More Information
Article History
Received: 10 September 2024
Accepted: 30 September 2025
First Online: 11 November 2025
Competing interests
: J.T.L. is a cofounder Fulcrum Therapeutics, an Advisor to Skyhawk Therapeutics, and a non-Executive Director of the GSK. The remaining authors declare no competing interests.
